查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1847186

美国标准週边血管器械市场：市场规模、份额和趋势分析（2025-2031 年）

Standard Peripheral Vascular Device Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Carotid Shunts, Introducer Sheath, Transcatheter Embolization, and 5 more
出版日期: | 出版商: iData Research Inc. | 英文 219 Pages | 商品交期: 最快1-2个工作天内

价格
如有价格方面的疑问请按下「询问」键来信查询

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年美国标准週边血管器械市场价值超过 27 亿美元，预计到 2031 年将达到超过 35 亿美元。

本报告涵盖下腔静脉滤器和取栓器、颈动脉分流器、经颈动脉血管重组血流逆转系统和支架、诊断和介入性导管、诊断和介入导管导引线、导引鞘、血管闭合装置和经导管栓塞治疗装置。

虽然其中一些技术也可以用于冠状动脉手术，但本研究中的所有尺寸和投影都仅适用于週边手术。

该研究量化了单位销售、平均售价、市场规模、成长率、手术数量和企业市场占有率。

它还分析了市场驱动因素和限制因素、併购、投资组合以及医院、门诊设施和办公室实验室的竞争格局。

市场概览

美国的周边血管治疗计画正不断转向动脉和静脉通路微创治疗。

导管导引线、导管、鞘套和栓塞工具在医院和诊所实验室中用于治疗各种疾病。

颈动脉保护和治疗可藉助颈动脉分流器和 TCAR 系统实现血流逆转和支架植入，从而起到神经保护作用；此外，还可使用下腔静脉滤器和取栓器，用于治疗有肺动脉栓塞风险的特定患者。

血管闭合装置用于经皮后，是实现当日出院和快速下床活动的关键。

从整个产品线来看，市场反映了几个广泛的主题。

首先，随着桡动脉入路方案和门诊病人復健目标的推进，手术方式已从侵入性缝合逐渐转向非侵入性血管外缝合。

其次，办公实验室的需求不断增长，使得价格分布、捆绑销售和供货情况变得更加重要。第三，仪器偏好与工作流程有密切关係。

亲水性导管和支撑导管可缩短手术时间并提高穿刺成功率。基于塞子和黏合剂的闭合系统因其易用性和良好的安全性而备受青睐。

最后，疾病意识的提高、人口老化以及静脉护理的持续发展（静脉疾病历来诊断不足或治疗不足）都对整个市场产生了影响。

市场驱动因素

静脉市场发展。静脉疾病仍然十分常见，并造成沉重的临床负担。美国每年约有60万肺动脉栓塞，其中大部分是由下肢深层静脉栓塞症引起的。约79%的肺动脉栓塞患者同时有深层静脉栓塞症栓塞的观察，而近端深层静脉栓塞症形成患者中高达一半也患有肺动脉栓塞。诊断极具挑战性。在相当一部分病例中，猝死是首发症状，而高达一半的患者则无症状。美国每年约有90万人患有深层静脉栓塞症。随着教育、筛检和治疗途径的扩展，週边静脉市场预计将会成长。

影像引导下的静脉介入治疗。血管内超音波的应用对深部静脉介入治疗具有重要意义。由于积极的临床实践和针对性的教育，在一些医疗机构中，血管内超音波在深部静脉手术中的应用率已超过50%。超音波有助于更准确地评估病灶和选择合适的支架尺寸，并提高同一手术中导管导引线、导管和鞘套的置入次数。

高血管再阻塞率促使患者进行后续干预。约三分之一的患者在球囊血管成形术后会血管再阻塞。在某些适应症中，再次手术支撑了对球囊、导管导引线、支撑导管和栓塞装置的稳定需求。在支架植入领域，支架内再血管再阻塞可能导致在相关市场进行斑块动脉粥状硬化斑块切除术和使用专用球囊清除斑块，同时也支撑了标准治疗室内对诊断和介入耗材的需求。

治疗场所正在不断发展。越来越多的周边手术在门诊和诊所实验室进行。这些场所需要能够缩短手术时间、标准化套件并实现当日出院的设备。非侵入性缝合技术可透过减少併发症和缩短恢復时间来满足这一需求。

市场限制

人们对紫杉醇的谨慎态度也反映在价格上。包衣药物的复杂程度更高，但2018年的安全讯号和2019年FDA的审查，造成了持续的谨慎情绪，并影响了采购行为。医院和诊所实验室正在仔细审查其所有周边设备的价值，即使是标准类别的产品，价格也因此承压。

诊所实验室的竞争与捆绑销售。诊所实验室的采购价格通常低于医院。供应商为争取优先供货地位而展开激烈竞争，并经常将鞘套、导管导引线和导管与其他器材捆绑销售。捆绑销售会降低平均售价，并对产品组合单一的小型公司构成挑战。市场力量的集中可能会减缓创新。

股腘动脉段逐渐成熟。随着股腘动脉区域的治疗趋于稳定，其成长速度将放缓，趋向于治疗趋势而非快速扩张。这将影响导丝、导管和闭合器等器械在这些路径中的通过。

市场和数据覆盖范围

定量覆盖范围：市场规模、市场占有率、市场预测、成长率、销售单位数量、平均售价、手术例数。

定性通报：成长趋势、市场限制、竞争分析、竞争对手 SWOT 分析、併购、公司简介和产品系列、FDA 批准和召回（如适用）、颠覆性技术、影响治疗方法方案的疾病概况。

时段：基准年 2024 年，预测期间 2025-2031 年，历史资料 2021-2023 年。

资料来源：对行业领导者的直接访谈、政府医生和程序资料、监管资料、医院和诊所实验室输入、进出口资料、iData Research 内部资料库。

方法收入以单位乘以平均售价 (ASP) 为模型，并根据装置量、手术组合、存取方式和设定变化检验。

目标市场及区隔

下腔静脉滤网市场

器械类型：下腔静脉滤器和下腔静脉滤器取出装置。

颈动脉分流术

经颈动脉重组（TCAR）

器械类型：经颈动脉裸金属支架和TCAR神经保护或血流逆转系统。

诊断和介入导管市场

器械类型：诊断导管和支撑导管。

诊断和介入导管导引线市场

装置类型：标准型和亲水性。

导引鞘市场

设备类型：标准型和导向型。

血管闭合装置市场

设备类型：非侵入式与侵入式。

入路：桡动脉和股动脉。

经导管栓塞市场

设备类型：颗粒、线圈、液体、插头。

入路：桡动脉和股动脉。

竞争分析

2024年，泰尔茂凭藉其导管导引线和血管闭合器械的强劲表现，在美国週边血管器械市场占据领先地位。该公司在诊断和介入导管以及导引器鞘套也占据领先地位。Terumo Corporation的Glidewire产品在亲水性导管领域占据主导地位，该产品将不褪色的镍钛合金芯与渗透性的护套相结合。其尖端较柔软的型号可增强可视性，以适应复杂的解剖结构。该公司透过选择性地降低导管导引线降价来维持市场份额。 2016年，Terumo Corporation收购了Angio-Seal和FemoSeal，巩固了在美国血管闭合器械市场的领先地位。

波士顿科学公司在2019年收购BTG后，凭藉产品组合的拓展，跃升至第二名。该公司在经经导管栓塞治疗装置处于领先地位，并凭藉VICI系统巩固了其在静脉支架领域的地位，而其长期畅销的Wallstent支架也继续贡献着市场份额。波士顿科学公司专注于肿瘤治疗和深层静脉栓塞症治疗，支撑了对栓塞器械和周边血管通路耗材的需求。

2024年，雅培血管（Abbott Vascular）占据了第三大市场份额，这主要得益于其在大直径血管闭合领域的统治地位。其缝合式系统，例如StarClosure、Perclose和Prostar XL，利用针头和结扎来封闭动脉通路。雅培在提高稳定性和易用性的同时，也降低了发炎风险。该公司在2024年几乎垄断了大直径介入性血管闭合手术市场。儘管随着新型单器械闭合解决方案的进入，雅培的地位可能会面临压力，但这些替代方案尚未获得相同的市场认可。

其他参与企业则在导管、导引线、鞘套、闭塞和栓塞领域竞争，其策略着重于涂层性能、推播性、视觉化以及为多中心团队和办公室实验室提供的服务支援。

科技与临床趋势

非侵入性和血管外闭合术的应用日益增加。当日出院计划倾向于选择能够减少併发症并促进早期下床活动的闭合装置。符合工作流程和安全目标的栓塞式和黏合剂式系统正逐渐占据市场份额。临床指引和健保报销政策也支持这项转变。

在条件允许的情况下，先考虑桡动脉入路。桡动脉入路有助于提高患者舒适度并促进早期活动，也适用于门诊和诊间检查流程。随着桡动脉使用率的提高，市场对顺应性导引器、亲水性导管以及专为桡动脉设计的血管闭合策略的需求也将随之增加。

亲水涂层和导管设计。成功通过取决于摩擦力、扭力和远端支撑。亲水性导管降低阻力。支撑导管可稳定係统并辅助器械输送。这些特性可缩短手术时间并减少併发症。

采用TCAR路径：血流逆转和神经保护是TCAR的核心。为此设计的系统正在拓展颈动脉治疗的选择范围。

丰富的栓塞治疗产品组合。临床医师可根据解剖结构和血流状况，选择颗粒、弹簧圈、液体和栓塞栓塞剂。输送系统具有更佳的推送性和控制性，可支援更精准的治疗。

护理机构

本报告涵盖医院、设有周边服务的区域医疗机构、门诊中心和诊所实验室。不同机构的差异会影响产品选择、套件标准化和定价。医院优先考虑库存充足和能够处理复杂病例。诊所实验室优先考虑成本、稳定的交付以及适合大量检测流程的简易套件。门诊中心优先考虑缩短住院时间和可预测的康復，因此支持使用非侵入性闭合装置和桡动脉入路。

为什么要写这份报告？

美国标准週边血管器材市场中最大且成长最快的机会是什么？到 2031 年，闭合器械、通路工具、诊断和介入性耗材、栓塞系统、颈动脉分流器和 TCAR 组件将如何各自创造价值？

标准周边设备市场与美国医疗保健提供者的整体格局有何关係？包括向门诊护理的转变、办公室实验室的成长以及预算和人员配备压力。

未来哪些因素将影响市场格局，包括非侵入性血管外闭合技术的兴起、桡动脉优先通讯协定以及依赖精确成像和器械输送的静脉通路的持续发展？

预计桡动脉入路和股动脉入路之间的平衡如何？这种选择将如何影响医院和门诊实验室对导引鞘、引导鞘套、闭合装置、亲水性导管和止血阀的需求？

栓塞术在创伤、止血和标靶治疗中的应用将如何发展？颗粒、弹簧圈、液体和栓塞剂的组合及输送系统的偏好又会如何改变？

TCAR 在哪些地区将经历最强劲的成长？神经保护系统的植入将如何促进支架拉出以及满足治疗颈动脉疾病的团队的服务需求？

iData Research 的《美国标准週边血管设备市场报告》透过细分和配置模型、企业市场占有率分析、程序和定价详情以及将通路和闭合选择与设备消费联繫起来的研究来回答这些问题。

利用这份报告来拓展览类机会、规划产品蓝图、使捆绑销售和合约与现场需求保持一致，并设定库存、服务和培训目标。

目录

图表清单

图表列表

美国标准週边血管器械市场概览

竞争分析

新兴市场与技术

市场趋势

市场趋势

流程分段

待调查的程式码

市场区隔

关键分析更新

版本历史记录

调查方法

全球关税的影响

美国标准週边血管器械市场概览

  • 介绍
    • 动脉硬化
    • 周边动脉疾病（垫片）
  • 市场概览及趋势分析
    • 复杂週边血管市场概述及趋势分析
    • 标准週边血管市场概述及趋势分析
  • 驾驶员和约束装置
  • 竞争市占率分析
  • 併购

手术次数

  • 介绍
  • 程式
    • 综合标准週边血管外科
    • 下腔静脉滤器手术
    • 颈动脉介入手术
    • 血管闭合装置手术
    • 经导管栓塞术

下腔静脉滤器和取栓装置市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 下腔静脉滤器和取栓装置市场总规模
    • IVCF 取出装置市场
  • 驾驶员和约束装置
  • 竞争市占率分析

颈动脉分流市场

  • 介绍
  • 市场分析与预测
  • 驾驶员和约束装置
  • 竞争市占率分析

经颈动脉重组市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 经颈动脉裸金属支架市场
    • TCAR神经保护系统市场
  • 驾驶员和约束装置
  • 竞争市占率分析

诊断和介入导管市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 诊断与介入导管总市场
    • 诊断导管市场整体状况
    • 导管支撑市场
  • 驾驶员和约束装置
  • 竞争市占率分析

诊断和介入导管导引线市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 诊断与介入导管导引线总市场
    • 标准导管导引线市场
    • 亲水导管导引线市场
  • 驾驶员和约束装置
  • 竞争市占率分析

导引鞘市场

  • 介绍
  • 市场概览
  • 市场分析与预测
    • 导引鞘市场
    • 标准导引鞘市场
    • 引导导引鞘市场
  • 驾驶员和约束装置
  • 竞争市占率分析

血管闭合装置市场

  • 介绍
  • 市场概览
    • 血管闭合器械市场概览（依器械类型划分）
    • 血管闭合装置市场概览（依方法分类）
  • 市场分析与预测
    • 血管闭合装置市场整体状况
    • 血管闭合器械市场（依器械类型划分）
    • 依方法分類的血管闭合装置市场
  • 驾驶员和约束装置
  • 竞争市占率分析

经导管栓塞装置市场

  • 介绍
    • 颗粒栓塞
    • 线圈栓塞术
    • 液体栓塞
    • 血管栓塞
  • 市场概览
  • 市场分析与预测
    • 经导管栓塞装置总市场
    • 颗粒栓塞市场整体状况
    • 整体线圈栓塞市场
    • 液态栓塞市场
    • 栓塞市场
  • 驾驶员和约束装置
  • 竞争市占率分析

简称

Product Code: iDATA_USSPV25_MS

The U.S. standard peripheral vascular device market was valued at over $2.7 billion in 2024. The market is expected to reach over $3.5 billion by 2031.

This report suite covers inferior vena cava filters and retrieval devices, carotid shunts, transcarotid arterial revascularization flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices, and transcatheter embolization devices.

While some of these technologies can be used in coronary care, all sizing and forecasts in this study reflect peripheral procedures only.

The research quantifies unit sales, average selling prices, market size, growth rates, procedure numbers, and company shares.

It also analyzes market drivers and limiters, mergers and acquisitions, portfolios, and the competitive landscape across hospitals, ambulatory sites, and office based labs.

Market Overview

Peripheral vascular programs in the United States continue to shift toward minimally invasive care across arterial and venous pathways.

Hospitals and office based labs rely on guidewires, catheters, sheaths, and embolization tools for a wide range of indications.

Carotid protection and treatment are supported by carotid shunts and TCAR systems that allow flow reversal and stenting with neuroprotection. Inferior vena cava filters and retrieval devices address selected patients at risk for pulmonary embolism.

Vascular closure devices are used after percutaneous access and are central to same day discharge and rapid ambulation goals.

Across product lines, the market reflects several broad themes.

First, there is steady movement from invasive or suture-based closure toward non-invasive and extravascular options, in line with radial access protocols and outpatient recovery targets.

Second, demand in office based labs keeps growing, which raises the importance of price corridors, bundles, and consistent supply. Third, device preference is linked to workflow.

Hydrophilic guidewires and supportive catheters shorten case time and improve crossing success. Plug-based and adhesive-based closure systems are valued for ease of use and favorable safety profiles.

Finally, the overall market is influenced by disease awareness, aging demographics, and the continued development of venous treatments that were historically underdiagnosed or undertreated.

Market Drivers

Venous market development. Venous disease remains common and is a major clinical burden. The United States records about 600,000 pulmonary embolism cases per year. Most originate from deep vein thrombosis in the legs. About 79 percent of patients who present with pulmonary embolism show evidence of deep vein thrombosis, and pulmonary embolism occurs in up to half of patients with proximal deep vein thrombosis. Diagnosis can be difficult. Sudden death is the first symptom in a meaningful share of cases, and up to half of patients have no symptoms. About 900,000 people in the United States are affected by deep vein thrombosis each year. As education, screening, and treatment pathways expand, the venous segment of the peripheral market is expected to grow.

Imaging-guided venous interventions. Adoption of intravascular ultrasound is closely linked to deep venous work. Following positive clinical experience and targeted education, penetration of intravascular ultrasound in deep venous procedures already exceeds 50 percent in some programs. Wider use of intravascular ultrasound supports more accurate lesion assessment and stent sizing, which lifts pull-through for guidewires, catheters, and sheaths within the same case.

High restenosis rates drive follow-up intervention. Roughly one third of patients experience re-narrowing after balloon angioplasty. Repeat procedures support steady demand for balloons, guidewires, support catheters, and embolization devices in specific indications. In stented segments, in-stent restenosis can lead to plaque removal with atherectomy or specialty balloons in adjacent markets, and it also supports demand for diagnostic and interventional consumables within the standard suite.

Site of care evolution. More peripheral cases are performed in ambulatory settings and office based labs. These sites prize devices that shorten procedure time, standardize kits, and enable same day discharge. Non-invasive closure technologies fit this need by reducing complications and recovery time.

Market Limiters

Paclitaxel caution spills over to price sensitivity. Although drug-coated products are detailed more deeply in complex suites, the 2018 safety signal and the 2019 FDA review created long-lasting caution that influences purchasing behavior. Hospitals and office based labs scrutinize value across the basket of peripheral tools, which adds pressure to pricing in standard categories as well.

Competition and bundling in office based labs. Office based labs buy at prices that are already below hospital levels. Vendors compete hard for preferred supplier status and often bundle sheaths, guidewires, and catheters with other devices. Bundles lower average selling prices and can challenge smaller firms with narrower portfolios. If market power concentrates, innovation can slow.

Maturing femoral-popliteal segment. As treatment practices become stable in the femoral-popliteal region, growth moderates toward procedural trends rather than rapid expansion. This affects pull-through for wires, catheters, and closure products used in those pathways.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, average selling prices, and procedure numbers.

Qualitative coverage. Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA clearances and recalls where relevant, disruptive technologies, and disease overviews that influence therapy selection.

Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.

Data sources. Primary interviews with industry leaders, government physician and procedure data, regulatory data, hospital and office based lab inputs, import and export data, and the iData Research internal database.

Method note. Revenues are modeled as units multiplied by ASP and validated against installed base, procedure mix, access approach, and setting shifts.

Markets Covered and Segmentation

Inferior Vena Cava Filter Market

Device type. IVC filter and IVC filter retrieval device.

Carotid Shunt

Transcarotid Artery Revascularization (TCAR)

Device type. Transcarotid bare-metal stent and TCAR neuroprotection or flow reversal system.

Diagnostic and Interventional Catheter Market

Device type. Diagnostic catheter and support catheter.

Diagnostic and Interventional Guidewire Market

Device type. Standard and hydrophilic.

Introducer Sheath Market

Device type. Standard and guiding.

Vascular Closure Device Market

Device type. Non-invasive and invasive.

Approach. Radial and femoral.

Transcatheter Embolization Market

Device type. Particle, coil, liquid, and plug.

Approach. Radial and femoral.

Competitive Analysis

Terumo led the U.S. peripheral vascular device market in 2024 on the strength of guidewires and vascular closure devices. The company also held top positions in diagnostic and interventional catheters and in introducer sheaths. Terumo dominated the hydrophilic guidewire segment with Glidewire products that combine a kink-resistant nitinol core and a radiopaque jacket. Variants with softer tips and enhanced visibility serve complex anatomy. The company has used selective price reductions on guidewires to protect share. Terumo secured leadership in the U.S. closure device market after acquiring Angio-Seal and FemoSeal in 2016

Boston Scientific ranked second after expanding its portfolio with the 2019 acquisition of BTG. The company leads in transcatheter embolization devices and holds positions in venous stents with the VICI system, while the long-standing Wallstent continues to contribute share. Boston Scientific has focused on oncology and deep vein thrombosis care, which supports demand for embolization tools and peripheral access consumables.

Abbott Vascular held the third-largest share in 2024, driven by dominance in large-bore vascular closure. Suture-mediated systems such as StarClose, Perclose, and ProStar XL seal arterial access with needles and knots. Abbott has improved stability and ease of use while reducing inflammation risk. The company held a near monopoly in large-bore invasive closure in 2024. Its position may face pressure as newer single-device closure solutions enter the market, but those alternatives have not yet reached the same traction.

Other participants compete across catheters, wires, sheaths, closure, and embolization with strategies that focus on coating performance, pushability, visualization, and service support for multi-site groups and office based labs.

Technology and Practice Trends

Non-invasive and extravascular closure gains. Programs that target same day discharge favor closure devices that reduce complications and allow faster ambulation. Plug-based and adhesive-based systems are gaining share where they fit workflow and safety goals. Clinical guidance and reimbursement support this shift.

Radial first where appropriate. Radial access supports patient comfort and earlier mobilization. It also aligns with outpatient and office based lab pathways. As radial use grows, demand shifts toward compatible introducers, hydrophilic guidewires, and closure strategies designed for radial arteries.

Hydrophilic coatings and supportive catheter design. Crossing success depends on friction, torque, and distal support. Hydrophilic guidewires reduce resistance. Support catheters stabilize the system and aid device delivery. These features reduce case time and limit complications.

TCAR pathway adoption. Flow reversal and neuroprotection are central to TCAR. Systems designed for this approach are expanding the options for carotid treatment.

Embolization portfolio breadth. Physicians choose among particles, coils, liquids, and plugs based on anatomy and flow. Delivery systems are improving in pushability and control, which supports more targeted therapy.

Care Settings

The report covers hospitals, community sites with peripheral programs, ambulatory centers, and office based labs. Site differences affect product choice, kit standardization, and price. Hospitals value broad inventory and support for complex cases. Office based labs focus on cost, consistent delivery, and simple kits that match high-volume protocols. Ambulatory centers target short stays and predictable recovery, which supports non-invasive closure devices and radial access where indicated.

Why This Report

Where is the largest and fastest growing opportunity within the U.S. standard peripheral vascular device market, and how do closure devices, access tools, diagnostic and interventional consumables, embolization systems, carotid shunts, and TCAR components each contribute to value through 2031.

How does the standard peripheral device market relate to the broader U.S. provider landscape, including the shift to outpatient care, growth of office based labs, and pressure on budgets and staffing.

What forces will shape the market going forward, including the rise of non-invasive and extravascular closure, radial first protocols, and the continued development of venous pathways that rely on accurate imaging and device delivery.

What is the expected balance between radial and femoral access, and how will this choice change demand for introducer sheaths, guiding sheaths, closure devices, hydrophilic guidewires, and hemostasis valves across hospitals and office based labs.

How will embolization usage evolve across trauma, bleeding control, and targeted therapy, and what does this mean for the mix of particles, coils, liquids, and plugs, as well as delivery system preferences.

Where will TCAR see the most consistent growth, and how will neuroprotection system placements drive stent pull-through and service requirements for teams that manage carotid disease.

The U.S. standard peripheral vascular device market report from iData Research answers these questions with segment and setting models, company share analysis, procedure and pricing detail, and coverage that links access and closure choices to device consumption.

Use it to size opportunities by category, plan product roadmaps, align bundles and contracts with site needs, and set targets for inventory, service, and training.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

U.S. Standard Peripheral Vascular Device Market Overview

Competitive Analysis

Emerging Markets And Technologies

Market Trends

Market Developments

Procedure Segmentation

Procedure Codes Investigated

Market Segmentation

Key Analysis Updates

Version History

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

U.S. Standard Peripheral Vascular Device Market Overview

  • 3.1 Introduction
    • 3.1.1 Atherosclerosis
    • 3.1.2 Peripheral Arterial Disease (Pad)
  • 3.2 Market Overview & Trend Analysis
    • 3.2.1 Complex Peripheral Vascular Market Overview & Trend Analysis
    • 3.2.2 Standard Peripheral Vascular Market Overview & Trend Analysis
  • 3.3 Drivers And Limiters
    • 3.3.1 Market Drivers
    • 3.3.2 Market Limiters
  • 3.4 Competitive Market Share Analysis
  • 3.5 Mergers And Acquisitions

Procedure Numbers

  • 4.1 Introduction
  • 4.2 Procedures
    • 4.2.1 Total Standard Peripheral Vascular Procedures
    • 4.2.2 Inferior Vena Cava Filter Procedures
      • 4.2.2.1 Inferior Vena Cava Filter Procedures By Procedure Type
      • 4.2.2.1.1 Ivcf Placement Procedures By Device Type
    • 4.2.3 Carotid Intervention Procedures
      • 4.2.3.1 Carotid Intervention Procedures By Procedure Type
    • 4.2.4 Vascular Closure Device Procedures
      • 4.2.4.1 Vascular Closure Device Procedures By Device Type
      • 4.2.4.1.1 Invasive Vascular Closure Procedures By Device Size
      • 4.2.4.2 Vascular Closure Procedures By Approach
    • 4.2.5 Transcatheter Embolization Procedures
      • 4.2.5.1 Transcatheter Embolization Procedures By Device Type
      • 4.2.5.1.1 Transcatheter Particle Embolization Procedures By Device Type
      • 4.2.5.1.2 Transcatheter Coil Embolization Procedures By Device Type

Inferior Vena Cava Filter & Retrieval Device Market

  • 5.1 Introduction
  • 5.2 Market Overview
  • 5.3 Market Analysis And Forecast
    • 5.3.1 Total Inferior Vena Cava Filter & Retrieval Device Market
      • 5.3.1.1 Retrievable Ivcf Market
      • 5.3.1.2 Permanent Ivcf Market
    • 5.3.2 Ivcf Retrieval Device Market
  • 5.4 Drivers And Limiters
    • 5.4.1 Market Drivers
    • 5.4.2 Market Limiters
  • 5.5 Competitive Market Share Analysis

Carotid Shunt Market

  • 6.1 Introduction
  • 6.2 Market Analysis And Forecast
  • 6.3 Drivers And Limiters
    • 6.3.1 Market Drivers
    • 6.3.2 Market Limiters
  • 6.4 Competitive Market Share Analysis

Transcarotid Artery Revascularization Market

  • 7.1 Introduction
  • 7.2 Market Overview
  • 7.3 Market Analysis And Forecast
    • 7.3.1 Transcarotid Bare-Metal Stent Market
    • 7.3.2 Tcar Neuroprotection System Market
  • 7.4 Drivers And Limiters
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 Competitive Market Share Analysis

Diagnostic & Interventional Catheter Market

  • 8.1 Introduction
  • 8.2 Market Overview
  • 8.3 Market Analysis And Forecast
    • 8.3.1 Total Diagnostic And Interventional Catheter Market
    • 8.3.2 Total Diagnostic Catheter Market
      • 8.3.2.1 Standard Diagnostic Catheter Market
      • 8.3.2.2 Hydrophilic Diagnostic Catheter Market
    • 8.3.3 Support Catheter Market
  • 8.4 Drivers And Limiters
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 Competitive Market Share Analysis

Diagnostic & Interventional Guidewire Market

  • 9.1 Introduction
  • 9.2 Market Overview
  • 9.3 Market Analysis And Forecast
    • 9.3.1 Total Diagnostic And Interventional Guidewire Market
    • 9.3.2 Standard Guidewire Market
    • 9.3.3 Hydrophilic Guidewire Market
  • 9.4 Drivers And Limiters
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 Competitive Market Share Analysis

Introducer Sheath Market

  • 10.1 Introduction
  • 10.2 Market Overview
  • 10.3 Market Analysis And Forecast
    • 10.3.1 Total Introducer Sheath Market
    • 10.3.2 Standard Introducer Sheath Market
    • 10.3.3 Guiding Introducer Sheath Market
  • 10.4 Drivers And Limiters
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 Competitive Market Share Analysis

Vascular Closure Device Market

  • 11.1 Introduction
  • 11.2 Market Overview
    • 11.2.1 Vascular Closure Device Market Overview By Device Type
    • 11.2.2 Vascular Closure Device Market Overview By Approach
  • 11.3 Market Analysis And Forecast
    • 11.3.1 Total Vascular Closure Device Market
    • 11.3.2 Vascular Closure Device Market By Device Type
      • 11.3.2.1 Non-Invasive Vascular Closure Device Market
      • 11.3.2.2 Total Invasive Vascular Closure Device Market
      • 11.3.2.2.1 Small-Bore Invasive Vcd Market
      • 11.3.2.2.2 Large-Bore Invasive Vcd Market
    • 11.3.3 Vascular Closure Device Market By Approach
      • 11.3.3.1 Radial Vcd Market
      • 11.3.3.2 Femoral Vcd Market
  • 11.4 Drivers And Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Transcatheter Embolization Device Market

  • 12.1 Introduction
    • 12.1.1 Particle Embolics
    • 12.1.2 Coil Embolics
    • 12.1.3 Liquid Embolics
    • 12.1.4 Vascular Plugs
  • 12.2 Market Overview
  • 12.3 Market Analysis And Forecast
    • 12.3.1 Total Transcatheter Embolization Device Market
    • 12.3.2 Total Particle Embolization Market
      • 12.3.2.1 Pva Particle Embolization Market
      • 12.3.2.2 Microsphere Particle Embolization Market
      • 12.3.2.3 Drug-Eluting Particle Embolization Market
      • 12.3.2.4 Radioactive Particle Embolization Market
    • 12.3.3 Total Coil Embolization Market
      • 12.3.3.1 Pushable Coil Market
      • 12.3.3.2 Detachable Coil Market
    • 12.3.4 Liquid Embolization Market
    • 12.3.5 Plug Embolization Market
  • 12.4 Drivers And Limiters
    • 12.4.1 Market Drivers
    • 12.4.2 Market Limiters
  • 12.5 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Standard Peripheral Vascular Device Market by Segment, U.S., 2024 - 2031
  • Chart 1-2: Standard Peripheral Vascular Device Market Overview, U.S., 2024 & 2031
  • Chart 3-1: Complex Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031
  • Chart 3-2: Standard Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031
  • Chart 3-3: Leading Competitors, Standard Peripheral Vascular Device Market, U.S., 2024
  • Chart 4-1: Standard Peripheral Vascular Procedures by Segment, U.S., 2021 - 2031
  • Chart 5-1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2021 - 2031
  • Chart 5-2: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2024
  • Chart 6-1: Carotid Shunt Market, U.S., 2021 - 2031
  • Chart 6-2: Leading Competitors, Carotid Shunt Market, U.S., 2024
  • Chart 7-1: Transcarotid Artery Revascularization Market by Segment, U.S., 2021 - 2031
  • Chart 8-1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2021 - 2031
  • Chart 8-2: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2024
  • Chart 9-1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2021 - 2031
  • Chart 9-2: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2024
  • Chart 10-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031
  • Chart 10-2: Leading Competitors, Introducer Sheath Market, U.S., 2024
  • Chart 11-1: Vascular Closure Device Market by Device Type, U.S., 2021 - 2031
  • Chart 11-2: Vascular Closure Device Market by Approach, U.S., 2021 - 2031
  • Chart 11-3: Leading Competitors, Vascular Closure Device Market, U.S., 2024
  • Chart 12-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031
  • Chart 12-2: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024

LIST OF FIGURES

  • Figure 1-1: Standard Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2024 (1 of 2)
  • Figure 1-2: Standard Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2024 (2 of 2)
  • Figure 1-3: Companies Researched in This Report (1 of 2)
  • Figure 1-4: Companies Researched in This Report (2 of 2)
  • Figure 1-5: Factors Impacting the Standard Peripheral Vascular Device Market by Segment, U.S. (1 of 2)
  • Figure 1-6: Factors Impacting the Standard Peripheral Vascular Device Market by Segment, U.S. (2 of 2)
  • Figure 1-7: Recent Events in the Peripheral Vascular Device Market, U.S., 2019 - 2025
  • Figure 1-8: Peripheral Vascular Device Procedures Covered by Indication (1 of 3)
  • Figure 1-9: Peripheral Vascular Device Procedures Covered by Indication (2 of 3)
  • Figure 1-10: Peripheral Vascular Device Procedures Covered by Indication (3 of 3)
  • Figure 1-11: Standard Peripheral Vascular Device Procedures Covered by Device Type
  • Figure 1-12: Complex Peripheral Vascular Device Procedures Covered by Device Type (1 of 4)
  • Figure 1-13: Complex Peripheral Vascular Device Procedures Covered by Device Type (2 of 4)
  • Figure 1-14: Complex Peripheral Vascular Device Procedures Covered by Device Type (3 of 4)
  • Figure 1-15: Complex Peripheral Vascular Device Procedures Covered by Device Type (4 of 4)
  • Figure 1-16: Procedure Codes Investigated
  • Figure 1-17: Standard Peripheral Vascular Device Market Segmentation (1 of 2)
  • Figure 1-18: Standard Peripheral Vascular Device Market Segmentation (2 of 2)
  • Figure 1-19: Complex Peripheral Vascular Device Market Segmentation (1 of 4)
  • Figure 1-20: Complex Peripheral Vascular Device Market Segmentation (2 of 4)
  • Figure 1-21: Complex Peripheral Vascular Device Market Segmentation (3 of 4)
  • Figure 1-22: Complex Peripheral Vascular Device Market Segmentation (4 of 4)
  • Figure 1-23: Key Analysis Updates
  • Figure 1-24: Version History
  • Figure 3-1: Complex Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
  • Figure 3-2: Complex Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
  • Figure 3-3: Standard Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
  • Figure 3-4: Standard Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
  • Figure 3-5: Leading Competitors, Standard Peripheral Vascular Device Market, U.S., 2024 (1 of 2)
  • Figure 3-6: Leading Competitors, Standard Peripheral Vascular Device Market, U.S., 2024 (2 of 2)
  • Figure 4-1: Procedure Codes Investigated, U.S., 2024
  • Figure 4-2: Standard Peripheral Vascular Procedures by Segment, U.S., 2021 - 2031
  • Figure 4-3: Inferior Vena Cava Filter Procedures by Procedure Type, U.S., 2021 - 2031
  • Figure 4-4: IVCF Placement Procedures by Device Type, U.S., 2021 - 2031
  • Figure 4-5: Carotid Intervention Procedures by Procedure Type, U.S., 2021 - 2031
  • Figure 4-6: Vascular Closure Device Procedures by Device Type, U.S., 2021 - 2031
  • Figure 4-7: Invasive Vascular Closure Procedures by Device Size, U.S., 2021 - 2031
  • Figure 4-8: Vascular Closure Procedures by Approach, U.S., 2021 - 2031
  • Figure 4-9: Transcatheter Embolization Procedures by Device Type, U.S., 2021 - 2031
  • Figure 4-10: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2021 - 2031
  • Figure 4-11: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2021 - 2031
  • Figure 5-1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 5-2: Retrievable IVCF Market, U.S., 2021 - 2031
  • Figure 5-3: Permanent IVCF Market, U.S., 2021 - 2031
  • Figure 5-4: IVCF Retrieval Device Market, U.S., 2021 - 2031
  • Figure 5-5: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2024
  • Figure 6-1: Carotid Shunt Market, U.S., 2021 - 2031
  • Figure 6-2: Leading Competitors, Carotid Shunt Market, U.S., 2024
  • Figure 7-1: Transcarotid Artery Revascularization Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 7-2: Transcarotid Bare-Metal Stent Market, U.S., 2021 - 2031
  • Figure 7-3: TCAR Neuroprotection System Market, U.S., 2021 - 2031
  • Figure 7-4: Leading Competitors, Transcarotid Artery Revascularization Market, U.S., 2024
  • Figure 8-1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 8-2: Total Diagnostic & Interventional Catheter Market, U.S., 2021 - 2031
  • Figure 8-3: Diagnostic Catheter Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 8-4: Total Diagnostic Catheter Market, U.S., 2021 - 2031
  • Figure 8-5: Standard Diagnostic Catheter Market, U.S., 2021 - 2031
  • Figure 8-6: Hydrophilic Diagnostic Catheter Market, U.S., 2021 - 2031
  • Figure 8-7: Support Catheter Market, U.S., 2021 - 2031
  • Figure 8-8: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2024
  • Figure 9-1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 9-2: Total Diagnostic & Interventional Guidewire Market, U.S., 2021 - 2031
  • Figure 9-3: Standard Guidewire Market, U.S., 2021 - 2031
  • Figure 9-4: Hydrophilic Guidewire Market, U.S., 2021 - 2031
  • Figure 9-5: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2024
  • Figure 10-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 10-2: Total Introducer Sheath Market, U.S., 2021 - 2031
  • Figure 10-3: Standard Introducer Sheath Market, U.S., 2021 - 2031
  • Figure 10-4: Guiding Introducer Sheath Market, U.S., 2021 - 2031
  • Figure 10-5: Leading Competitors, Introducer Sheath Market, U.S., 2024
  • Figure 11-1: Vascular Closure Device Market by Device Type, U.S., 2021 - 2031 (US$M)
  • Figure 11-2: Vascular Closure Device Market by Approach, U.S., 2021 - 2031 (US$M)
  • Figure 11-3: Total Vascular Closure Device Market, U.S., 2021 - 2031
  • Figure 11-4: Non-Invasive VCD Market, U.S., 2021 - 2031
  • Figure 11-5: Invasive Vascular Closure Device Market by Application, U.S., 2021 - 2031 (US$M)
  • Figure 11-6: Total Invasive Vascular Closure Device Market, U.S., 2021 - 2031
  • Figure 11-7: Small-Bore Invasive VCD Market, U.S., 2021 - 2031
  • Figure 11-8: Large-Bore Invasive VCD Market, U.S., 2021 - 2031
  • Figure 11-9: Radial VCD Market, U.S., 2021 - 2031
  • Figure 11-10: Femoral VCD Market, U.S., 2021 - 2031
  • Figure 11-11: Leading Competitors by Device Type, Vascular Closure Device Market, U.S., 2024
  • Figure 11-12: Leading Competitors, Invasive Vascular Closure Device Market, U.S., 2024
  • Figure 11-13: Leading Competitors by Approach, Vascular Closure Device Market, U.S., 2024
  • Figure 12-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 12-2: Total Transcatheter Embolization Device Market, U.S., 2021 - 2031
  • Figure 12-3: Particle Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 12-4: Total Embolization Particle Market, U.S., 2021 - 2031
  • Figure 12-5: PVA Particle Embolization Market, U.S., 2021 - 2031
  • Figure 12-6: Microsphere Particle Embolization Market, U.S., 2021 - 2031
  • Figure 12-7: Drug-Eluting Particle Embolization Market, U.S., 2021 - 2031
  • Figure 12-8: Radioactive Particle Embolization Market, U.S., 2021 - 2031
  • Figure 12-9: Coil Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
  • Figure 12-10: Total Coil Embolization Market, U.S., 2021 - 2031
  • Figure 12-11: Pushable Coil Market, U.S., 2021 - 2031
  • Figure 12-12: Detachable Coil Market, U.S., 2021 - 2031
  • Figure 12-13: Liquid Embolization Market, U.S., 2021 - 2031
  • Figure 12-14: Plug Embolization Market, U.S., 2021 - 2031
  • Figure 12-15: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024
  • Figure 12-16: Leading Competitors, Particle Embolization Market, U.S., 2024
  • Figure 12-17: Leading Competitors, Coil Embolization Market, U.S., 2024